South and Central America Sequencing Reagents Market Key Players and Opportunities by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028South and Central America Sequencing Reagents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Next Generation Sequencing, Sanger Sequencing, and Third Generation Sequencing), Application (Agrigenomics and Forensics, Clinical Investigation, Oncology, Reproductive Health, and Other Applications), Reagent Type (Control Kits, Library Kits, Template Kits, Sequencing Kits, and Other Reagent Types), and End User (Hospitals and Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users)
- Report Date : Jun 2021
- Report Code : TIPRE00022832
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 143
The South and Central America sequencing reagents market is expected to reach US$ 737.60 million by 2028 from US$ 342.80 million in 2021; it is estimated to grow at a CAGR of 11.6% from 2021 to 2028.
The growth of the market is attributed to a few key driving factors such as the increasing volume of funding activities for various research studies and the declining cost of sequencing procedures. However, the dearth of skilled professionals hinders the market growth.
Sequencing reagents are used during the process of sequencing. The use of these reagents highly depends on the desired result to be obtained. They form an essential part of the sequencing reactions, which can be used across various other applications as well. Now, sequencing reagents is increasingly used in clinical practice, and over the next five years, genomic data from over 60 million patients is expected to be generated within healthcare. Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investment, totaling over US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for broader adoption, thereby driving the growth of the sequencing reagent market. In addition, continuous funding by manufacturers and governments in the field of genomics is expected to bolster the market growth during the forecast period. In the recent years, next generation sequencing price have declined substantially. Owing to factors such as advances in the field of genomics and developments in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, which is propelling the market growth.
With the second wave of COVID-19 outbreak, there has been an increasing number of confirmed cases in Latin American countries. Currently, Brazil is rapidly increasing its clinical programs to fight against the novel coronavirus. There is a rising focus on genomic sequencing and tests. For instance, in July 2020, Vale Institute of Technology (ITV) and Fiocruz announced that they are planning to carry out the most extensive genome sequencing study of the Sars-CoV-2. Vale invested R$ 2.4 million in the research. Such initiatives would bolster the growth of the South and Central America sequencing reagents market in long run.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
SOUTH AND CENTRAL AMERICA SEQUENCING REAGENTS MARKET SEGMENTATION
By Technology
- Next Generation Sequencing
- Sanger Sequencing
- Third Generation Sequencing
By Reagent Type
- Control Kits
- Library Kits
- Template Kits
- Sequencing Kits
- Other Reagent Types
By Application
- Agri genomics and Forensics
- Clinical Investigation
- Oncology
- Reproductive Health
- Other Applications
By End User
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical and Biotechnology Companies
- Other End Users
By Country
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- QIAGEN
- Takara Bio Inc.
- THERMO FISHER SCIENTIFIC INC.
- TriLink BioTechnologies Inc
- F. HOFFMANN-LA ROCHE LTD.
- Illumina, Inc.
- FLUIDIGM CORPORATION
- LGC Biosearch Technologies
South and Central America Sequencing Reagents Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 342.80 Million |
| Market Size by 2028 | US$ 737.60 Million |
| Global CAGR (2021 - 2028) | 11.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- QIAGEN
- Takara Bio Inc.
- THERMO FISHER SCIENTIFIC INC.
- TriLink BioTechnologies Inc
- F. HOFFMANN-LA ROCHE LTD.
- Illumina, Inc.
- FLUIDIGM CORPORATION
- LGC Biosearch Technologies
Get Free Sample For